INS and type 1 diabetes mellitus: Low-frequency EMF (1 kHz) stimulation of 21 mT for 3 min per day effectively induced insulin secretion from the subcutaneously implanted EMPOWER-controlled designer cells and restored normoglycaemia in T1D mice over the entire 4-week experimental period.